Immune effects of ACE over-expression in neutrophils
中性粒细胞中 ACE 过度表达的免疫效应
基本信息
- 批准号:10176383
- 负责人:
- 金额:$ 42.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-11 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAngiotensin IIAngiotensin-Converting Enzyme InhibitorsArthritisAutoimmuneBradykininCardiovascular PhysiologyCatalytic DomainCell LineageCell physiologyCellsChemicalsCitric Acid CycleDataDevelopmentDiabetic NephropathyDiseaseEnzymesExhibitsExperimental Autoimmune EncephalomyelitisGiant CellsGranulomaHeart failureHematopoiesisHumanHypertensionImmuneImmune System DiseasesImmune responseImmunologicsImmunosuppressionIn VitroInfectionInflammatoryKidneyKlebsiella pneumoniaeKnowledgeLaboratoriesLeukocytesMHC Class I GenesMass Spectrum AnalysisMeasuresMetabolicModelingMusMyeloid CellsMyocarditisNADPH OxidaseNeutrophil ActivationParasitic infectionPathway interactionsPatientsPeptide HydrolasesPeptidesPeptidyl-Dipeptidase APharmacologic SubstancePhenotypePhosphorylationPhysiologicalPhysiologyPlayProductionProteinsPseudomonas aeruginosaRegulationRenin-Angiotensin SystemResidual stateResistanceRespiratory BurstRoleSepsisShapesSnake VenomsSuperoxidesUrinary tract infectionVasoconstrictor AgentsVasodilator AgentsWorkblood pressure reductionblood pressure regulationenzyme activityenzyme substrategenetic manipulationimmune functionmacrophagemalemethicillin resistant Staphylococcus aureusmonocyteneutrophilnoveloverexpressionpathogenpeptide Iprogramsreceptorreproductiveresponsetumor
项目摘要
Abstract - Angiotensin converting enzyme (ACE) is a peptidase that plays an important role in
blood pressure control. Millions of patients take ACE inhibitors. The first data suggesting that
ACE affects immune function were old studies documenting enhanced ACE production by the
monocytic lineage cells comprising a granuloma. When genetic manipulation in mice is used to
force over-expression of ACE in neutrophils or in monocytes and macrophages, these cells
respond with a marked enhancement of immune function, as measured in both tumor and
infection models. For example, mice over expressing ACE in neutrophils (NeuACE mice) have
increased resistance to MRSA, and better in vitro killing of MRSA, P. aeruginosa, and K.
pneumoniae. ACE over-expression increased neutrophil production of superoxide by NADPH
oxidase following MRSA challenge, an effect independent of the angiotensin II AT1 receptor.
These are very surprising and novel discoveries. The immune enhancement, a functional
supercharging, is what makes this work significant. Our hypothesis is that over-expression of
ACE alters the production or destruction of a peptide that has a remarkable developmental and
metabolic effect on myelomonocytic cells. The potential payoff of this work is that, previous to
our studies, there was nothing to suggest that ACE would have these immune effects. In other
words, there is a physiologic pathway that is still not well understood, the regulation of which
can achieve a marked enhancement of myelomonocytic cell function. Should we be able to
identify how ACE affects the immune response, we will have discovered something very novel
that could be manipulated to augment the immune response. We propose to study 1) where in
the developmental lineage of myelomonocytic cells, ACE over-expression begins to affect the
phenotype of the developing cells; 2) what are the metabolic effects of ACE over-expression
and which of the two ACE catalytic domains is responsible for the metabolic and enhanced
immune response seen in these cells. These data will be incorporated into a systematic
analysis using mass spectrometry to try to determine the ACE substrate responsible for the
enhanced immune response; and 3) how ACE over-expression leads to enhanced neutrophil
activation of NADPH oxidase and thus better killing of pathogens. Such knowledge will identify
a powerful but heretofore unknown means of regulating and enhancing the immune response.
摘要:血管紧张素转换酶(ACE)是一种肽酶,在
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH E BERNSTEIN其他文献
KENNETH E BERNSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH E BERNSTEIN', 18)}}的其他基金
Supplemental Grant: Increased neutrophil function in Alzheimer's disease
补充补助金:阿尔茨海默病中中性粒细胞功能增强
- 批准号:
10284911 - 财政年份:2021
- 资助金额:
$ 42.58万 - 项目类别:
The role of angiotensin-converting enzyme in renal inflammation, kidney injury and sodium retention during diabetic nephropathy
血管紧张素转换酶在糖尿病肾病肾脏炎症、肾损伤和钠潴留中的作用
- 批准号:
10188616 - 财政年份:2018
- 资助金额:
$ 42.58万 - 项目类别:
THE ROLE OF ACE IN INFLAMMATION AND HYPERTENSION
ACE 在炎症和高血压中的作用
- 批准号:
9978627 - 财政年份:2016
- 资助金额:
$ 42.58万 - 项目类别:
Carboxypeptidase ACE and MHC Class I Presentation
羧肽酶 ACE 和 MHC I 类介绍
- 批准号:
8969984 - 财政年份:2015
- 资助金额:
$ 42.58万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 42.58万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 42.58万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 42.58万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 42.58万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 42.58万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 42.58万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 42.58万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 42.58万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 42.58万 - 项目类别:
Metabolic and epigenetic regulation of cancer associated fibroblasts by angiotensin II
血管紧张素 II 对癌症相关成纤维细胞的代谢和表观遗传调控
- 批准号:
440714 - 财政年份:2020
- 资助金额:
$ 42.58万 - 项目类别:
Fellowship Programs














{{item.name}}会员




